These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 32719265)

  • 1. Salivary L-fucose as a biomarker for oral potentially malignant disorders and oral cancer.
    Sharma M; Sharma E; Prabhu V; Pai VR; D'souza JM; Harish S; Jose M
    J Cancer Res Ther; 2020; 16(3):546-550. PubMed ID: 32719265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sialic acid as a biomarker of oral potentially malignant disorders and oral cancer.
    Achalli S; Madi M; Babu SG; Shetty SR; Kumari S; Bhat S
    Indian J Dent Res; 2017; 28(4):395-399. PubMed ID: 28836530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the levels of salivary paxillin in oral potentially malignant disorders and malignant lesions.
    Hussine AA; Selim K; Shaker O; Kamal Y
    BMC Oral Health; 2024 Jul; 24(1):834. PubMed ID: 39048985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of serum and salivary dipeptidyl peptidase-4 (DPP-4) with oral cancerous and precancerous lesions; an observational diagnostic accuracy study.
    Abdel Fattah Tarrad N; Gamil Shaker O; Abdelkawy M; Hassan S
    BMC Oral Health; 2024 Oct; 24(1):1206. PubMed ID: 39390508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating levels in serum of total sialic acid, lipid-associated sialic acid, and fucose in precancerous lesion and cancer of the oral cavity.
    Rao VR; Krishnamoorthy L; Kumaraswamy SV; Ramaswamy G
    Cancer Detect Prev; 1998; 22(3):237-40. PubMed ID: 9618045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum and salivary interleukin-1β level in oral precancer: An observational study.
    Selvan TT; Patil RK; Singh V; Verma S; Tripathi A; Khanna V; Chaurasia A; Shetye AG
    J Cancer Res Ther; 2024 Apr; 20(3):788-792. PubMed ID: 39023584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Serum Fucose Levels in Leukoplakia and Oral Cancer Patients.
    Rai NP; Anekar J; Shivaraja Shankara YM; Divakar DD; Al Kheraif AA; Ramakrishnaiah R; Sebastian R; Raj AC; Al-Hazmi A; Mustafa SM
    Asian Pac J Cancer Prev; 2015; 16(17):7497-500. PubMed ID: 26625751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salivary and serum level of CYFRA 21-1 in oral precancer and oral squamous cell carcinoma.
    Rajkumar K; Ramya R; Nandhini G; Rajashree P; Ramesh Kumar A; Nirmala Anandan S
    Oral Dis; 2015 Jan; 21(1):90-6. PubMed ID: 24304502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum and salivary sialic acid as a biomarker in oral potentially malignant disorders and oral cancer.
    Dadhich M; Prabhu V; Pai VR; D'Souza J; Harish S; Jose M
    Indian J Cancer; 2014; 51(3):214-218. PubMed ID: 25494107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum fucosylation changes in oral cancer and oral precancerous conditions: alpha-L-fucosidase as a marker.
    Shah M; Telang S; Raval G; Shah P; Patel PS
    Cancer; 2008 Jul; 113(2):336-46. PubMed ID: 18521898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salivary Her2/neu Levels in Differentiation of Oral Premalignant Disorders and Oral Squamous Cell Carcinomas.
    Varun C; Dineshkumar T; Jayant VS; Rameshkumar A; Rajkumar K; Rajashree P; Mathew J; Arunvignesh RK
    Asian Pac J Cancer Prev; 2015; 16(14):5773-7. PubMed ID: 26320450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of salivary sialic acid as a tumor marker in tobacco chewers with oral cancer.
    Azeem MS; Yesupatham ST; Mohiyuddin SMA; Sumanth V; Ravishankar S
    J Cancer Res Ther; 2020; 16(3):605-611. PubMed ID: 32719275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimation of Salivary 8-Hydroxydeoxyguanosine (8-OHdG) as a Potential Biomarker in Assessing Progression towards Malignancy: A Case-Control Study.
    Nandakumar A; Nataraj P; James A; Krishnan R; K M M
    Asian Pac J Cancer Prev; 2020 Aug; 21(8):2325-2329. PubMed ID: 32856861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Salivary and Serum Alkaline Phosphates Level and Lactate Dehydrogenase Levels in Patients with Tobacco Related Oral Lesions with Healthy Subjects - A Step Towards Early Diagnosis.
    Goyal G
    Asian Pac J Cancer Prev; 2020 Apr; 21(4):983-991. PubMed ID: 32334459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of Mucin1 in saliva in oral squamous cell carcinoma and oral potentially malignant disorders (case control study).
    Abdelwhab A; Shaker O; Aggour RL
    Oral Dis; 2023 May; 29(4):1487-1494. PubMed ID: 35080082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Saliva protein biomarkers to detect oral squamous cell carcinoma in a high-risk population in Taiwan.
    Yu JS; Chen YT; Chiang WF; Hsiao YC; Chu LJ; See LC; Wu CS; Tu HT; Chen HW; Chen CC; Liao WC; Chang YT; Wu CC; Lin CY; Liu SY; Chiou ST; Chia SL; Chang KP; Chien CY; Chang SW; Chang CJ; Young JD; Pao CC; Chang YS; Hartwell LH
    Proc Natl Acad Sci U S A; 2016 Oct; 113(41):11549-11554. PubMed ID: 27663741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ratio of Salivary Sialic Acid to Fucose as Tumor Markers in Potentially Malignant Disorders and Oral Cancer.
    Arthisri AS; Sathiyamoorthy A; Meenakshi B; Chandran CR
    Contemp Clin Dent; 2020; 11(2):131-135. PubMed ID: 33110325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of salivary endothelin-1 as a biomarker for oral cancer and precancer.
    Irfan S; Zaidi N; Tiwari K; Lal N; Srivastava AN; Singh S
    J Cancer Res Ther; 2024 Jul; 20(5):1420-1424. PubMed ID: 38102911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of serum lipids and lipoproteins as prognosticators in leukoplakia.
    Ganavi BS; Patil S; Rao RS
    J Contemp Dent Pract; 2014 May; 15(3):294-9. PubMed ID: 25307809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative evaluation of serum fucose in oral squamous cell carcinoma patients.
    Parwani RN; Parwani SR
    J Cancer Res Ther; 2011; 7(2):143-7. PubMed ID: 21768700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.